Page last updated: 2024-08-17

carbostyril and Hyperactivity, Motor

carbostyril has been researched along with Hyperactivity, Motor in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujita, Y; Hashimoto, K; Iyo, M; Matsuura, A	1
Amano, T; Asato, M; Hashimoto, K; Ikegami, D; Kuzumaki, N; Matsushima, Y; Nakamura, A; Narita, M; Niikura, K; Shiokawa, M; Suzuki, T; Takagi, S; Takei, D; Tsurukawa, Y	1
Bernardi, G; Brusa, L; Iani, C; Mercuri, NB; Moschella, V; Orlacchio, A	1
Avenet, P; Bergis, O; Boulay, D; Griebel, G	1
Ching, H; Pringsheim, T	1
Bai, X; Chen, M; Chen, X; Frye, SV; Jin, J; Roth, BL; Sassano, MF; Setola, V; Wetsel, WC; Zheng, L	1
Guimarães, FS; Leite, JV; Moreira, FA	1

Reviews

1 review(s) available for carbostyril and Hyperactivity, Motor

Article	Year
Aripiprazole for autism spectrum disorders (ASD). The Cochrane database of systematic reviews, 2012, May-16, Issue:5 Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Female; Humans; Hyperkinesis; Irritable Mood; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic	2012

Trials

1 trial(s) available for carbostyril and Hyperactivity, Motor

Article	Year
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine. Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1 Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats	2009

Article

Year

Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.

Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats

2009

Other Studies

5 other study(ies) available for carbostyril and Hyperactivity, Motor

Article	Year
Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine. Acta neuropsychiatrica, 2015, Volume: 27, Issue:3 Topics: Animals; Antipsychotic Agents; Behavior, Animal; Chromatography, Liquid; Cognition Disorders; D-Amino-Acid Oxidase; Drug Interactions; Excitatory Amino Acid Antagonists; Hyperkinesis; Male; Mice; Models, Animal; Motor Activity; Phencyclidine; Prepulse Inhibition; Quinolones; Receptors, N-Methyl-D-Aspartate; Serine; Sodium Benzoate	2015
Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer. European journal of pharmacology, 2008, Dec-14, Volume: 600, Issue:1-3 Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Hyperkinesis; Male; Mice; Mice, Inbred ICR; Morphine; Nucleus Accumbens; Piperazines; Prochlorperazine; Quinolones; Reward; Severity of Illness Index	2008
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:2 Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Plasma Membrane Transport Proteins; Glycine Plasma Membrane Transport Proteins; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Piperazines; Quinolones; Receptors, N-Methyl-D-Aspartate	2010
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists. Journal of medicinal chemistry, 2012, Aug-23, Volume: 55, Issue:16 Topics: Animals; Antipsychotic Agents; Aripiprazole; Arrestins; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Female; HEK293 Cells; Humans; Hyperkinesis; Ligands; Male; Mice; Mice, Knockout; Phencyclidine; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Structure-Activity Relationship	2012
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. European journal of pharmacology, 2008, Jan-14, Volume: 578, Issue:2-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Partial Agonism; Excitatory Amino Acid Antagonists; Glutamine; Haloperidol; Hyperkinesis; Ketamine; Locomotion; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Time Factors	2008